3/5
08:10 pm
mnkd
MannKind Corp (MNKD) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
Neutral
Report
MannKind Corp (MNKD) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
3/5
04:57 pm
mnkd
MannKind Announces Settlement of Convertible Senior Notes [Yahoo! Finance]
Low
Report
MannKind Announces Settlement of Convertible Senior Notes [Yahoo! Finance]
3/5
04:30 pm
mnkd
MannKind Announces Settlement of Convertible Senior Notes
Low
Report
MannKind Announces Settlement of Convertible Senior Notes
3/5
08:52 am
mnkd
MannKind (MNKD) had its price target lowered by Wedbush from $10.00 to $8.00. They now have an "outperform" rating on the stock.
Medium
Report
MannKind (MNKD) had its price target lowered by Wedbush from $10.00 to $8.00. They now have an "outperform" rating on the stock.
3/4
09:35 am
mnkd
MannKind to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
MannKind to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/4
09:00 am
mnkd
MannKind to Participate in Upcoming Investor Conferences
Low
Report
MannKind to Participate in Upcoming Investor Conferences
3/4
06:06 am
mnkd
MannKind Corporation (MNKD) Outlines Expansion Plans and Revenue Targets [Yahoo! Finance]
Neutral
Report
MannKind Corporation (MNKD) Outlines Expansion Plans and Revenue Targets [Yahoo! Finance]
3/3
06:14 pm
mnkd
MannKind (MNKD) was downgraded by
Weiss Ratings from "hold (c)" to "sell (d+)".
Low
Report
MannKind (MNKD) was downgraded by
Weiss Ratings from "hold (c)" to "sell (d+)".
2/28
09:25 pm
mnkd
MannKind at Oppenheimer: 2025 Revenue Jumps 46%, Eyes $450M+ in 2026 on Afrezza and FUROSCIX [Yahoo! Finance]
Medium
Report
MannKind at Oppenheimer: 2025 Revenue Jumps 46%, Eyes $450M+ in 2026 on Afrezza and FUROSCIX [Yahoo! Finance]
2/28
01:38 pm
mnkd
MannKind Corporation (MNKD): A Bull Case Theory [Yahoo! Finance]
Medium
Report
MannKind Corporation (MNKD): A Bull Case Theory [Yahoo! Finance]
2/27
11:41 am
mnkd
MannKind (MNKD) had its price target lowered by Wells Fargo & Company from $8.00 to $7.00. They now have an "overweight" rating on the stock.
Low
Report
MannKind (MNKD) had its price target lowered by Wells Fargo & Company from $8.00 to $7.00. They now have an "overweight" rating on the stock.
2/27
08:44 am
mnkd
MannKind (MNKD) had its "sector perform" rating reaffirmed by Royal Bank Of Canada. They now have a $3.50 price target on the stock.
Medium
Report
MannKind (MNKD) had its "sector perform" rating reaffirmed by Royal Bank Of Canada. They now have a $3.50 price target on the stock.
2/27
06:33 am
mnkd
Reassessing MannKind (MNKD) After Sharp Recent Share Price Declines [Yahoo! Finance]
Low
Report
Reassessing MannKind (MNKD) After Sharp Recent Share Price Declines [Yahoo! Finance]
2/26
06:45 pm
mnkd
Why MannKind Stock Tumbled on Thursday [Yahoo! Finance]
Low
Report
Why MannKind Stock Tumbled on Thursday [Yahoo! Finance]
2/26
05:06 pm
mnkd
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/26
05:06 pm
mnkd
MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations [Seeking Alpha]
Low
Report
MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations [Seeking Alpha]
2/26
03:37 pm
mnkd
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
2/26
08:17 am
mnkd
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
08:00 am
mnkd
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
High
Report
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2/25
12:58 pm
mnkd
MannKind (MNKD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
MannKind (MNKD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $11.00 price target on the stock.
2/19
09:00 am
mnkd
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Low
Report
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
2/18
09:00 am
mnkd
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Low
Report
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
2/15
07:12 pm
mnkd
MannKind's Afrezza Pediatric Review Sparks Questions On Undervaluation And Risk [Yahoo! Finance]
Low
Report
MannKind's Afrezza Pediatric Review Sparks Questions On Undervaluation And Risk [Yahoo! Finance]
2/14
05:35 pm
mnkd
Assessing MannKind (MNKD) Valuation After Afrezza Pediatric Expansion Progress And New Growth Initiatives [Yahoo! Finance]
Low
Report
Assessing MannKind (MNKD) Valuation After Afrezza Pediatric Expansion Progress And New Growth Initiatives [Yahoo! Finance]
2/12
06:37 am
mnkd
MannKind (NASDAQ:MNKD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
MannKind (NASDAQ:MNKD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.